C-peptide has been shown to decrease these effects when delivered in conjunction with insulin as a treatment for T1DM, and offers a potential therapy for T1DM patients to decrease the risk of cardiovascular comorbidity development [44,82,85,86]. The gene discussed is INS; the disease is type 1 diabetes mellitus.